Tagged with Fact

Global Over two years since the first cases of COVID-19, the world is still coming to terms with the virus. While vaccines have been developed and rolled out in record time in high-income countries, the developing world risks falling behind. Less than ten percent of the African continent has been vaccinated,…

Saudi Arabia Saudi Chemical Company Holding (SCCH), Saudi Arabia’s leading manufacturer of civil and military explosives, has been expanding its pharma sector footprint in recent years. Today, the company has capabilities across pharma distribution through SITCO Pharma, manufacturing (both for its own products and as a contract manufacturing organisation (CMO)) via AJA…

Saudi Arabia Mohamed Mazen Batterjee, managing director of Batterjee Pharma, explains how he has turned the business around since joining in 2014, the interplay between the firm’s contract and proprietary manufacturing operations, and how it differentiates itself in the competitive Saudi market.   The future is rosy. [Saudi Arabia] has good capabilities,…

Saudi Arabia SaudiVax intends to be the premier developer, manufacturer, and supplier of vaccines and biologics in Saudi Arabia and the MENA region, including halal vaccines. Co-Founder and Managing Director Professor Mazen Hassanain comments on the company’s ambitions, the opportunity that halal vaccines represent, how its J&J partnership will create the first…

Spain mAbxience’s CEO Emmanuelle Lepine highlights the company’s international expansion into highly regulated markets, new investment into its Spanish manufacturing facility, and its partnership with AstraZeneca on COVID-19 vaccine manufacturing in Argentina. As representatives from the US FDA carried out a Good Clinical Practice inspection in an adjacent office, Lepine outlined…

Saudi Arabia Waleed Mohammed Al-Shaqha PharD PhD outlines the important role that API manufacturer CAD plays within Saudi Arabia, the importance of local manufacturing within the supply chain more broadly, and how Vision 2030 is reshaping the country’s industry paradigm.   Today, international companies can see the value and the benefit of…

Saudi Arabia Medtronic’s country director for Saudi Arabia, Mohammed El Ansari, comments on the implications of the company’s decision to move to a direct presence in the Kingdom, positioning the affiliate as a career launchpad for local talent, the local manufacturing of ventilators, and why Medtronic considers Saudi Arabia a priority market.…

Africa Medicines for Africa’s Lenias Hwenda highlights the vast gaps in COVID-19 vaccine access globally, especially in Africa where just six percent of the population has been vaccinated. Hwenda argues that the time is now to boost the infrastructure for pharmaceutical manufacturing in Africa as a way out of this pandemic,…

China The latest news from Chinese pharma, including a new report showing that despite the increasing number of Priority Review and Breakthrough Therapy designations awarded within China, only two Accelerated Approval designations have been awarded since 2015. Elsewhere, Pfizer is utilising drone technology to promote health education in remote areas and…

Turkey While supporters of Turkey’s localization policy for pharmaceuticals implemented in 2016 applaud the changes it has brought, its opponents are awaiting a much-anticipated report by the World Trade Organization that could put an end to the policy and have global repercussions.   Five years after the launch of Turkey’s localization…

Global After a challenging 2020, and with more hurdles in sight, Bayer has been on an investment spree with a USD 2 billion acquisition of a San Diego-based biotech and manufacturing sites in Latin America and Norway.   Bayer had a challenging year in 2020. While the German giant argued in…

Turkey Okan Güner of Viatris Turkey introduces the company’s sizeable footprint in the country, including local manufacturing and explains the challenges of executing an integration of two companies during the COVID-19 pandemic. Güner outlines Viatris’ role within Turkey’s Vision 2023, the opportunities for their biosimilars pipeline, and their portfolio’s role in…